摘要
Bifurcation lesions, one of the complex coronary lesion subsets, are usually encountered in around 15%-25% of patients during percutenous coronary intervention （PCI）. The treatment of stenoses at a bifurcation poses an ongoing challenge for the interventional cardiologists1-3 as PCI for bifurcation lesions is associated with the reduced procedural success rate and increased angiographic restenosis, especially in the side branch, or even portends a potentially negative impact on long-term clinical outcomes.4,5 The use of drug-eluting stents is generally recommended during bifurcation lesion intervention as it could result in a lower rate of main vessel restenosis. However, side branch ostial residual stenosis and stent thrombosis remain worrisome.6,7
Bifurcation lesions, one of the complex coronary lesion subsets, are usually encountered in around 15%-25% of patients during percutenous coronary intervention （PCI）. The treatment of stenoses at a bifurcation poses an ongoing challenge for the interventional cardiologists1-3 as PCI for bifurcation lesions is associated with the reduced procedural success rate and increased angiographic restenosis, especially in the side branch, or even portends a potentially negative impact on long-term clinical outcomes.4,5 The use of drug-eluting stents is generally recommended during bifurcation lesion intervention as it could result in a lower rate of main vessel restenosis. However, side branch ostial residual stenosis and stent thrombosis remain worrisome.6,7
作者简介
Email：rj shenweifeng @ yahoo.com.cn
